Cloud laboratories make ‘compliance-by-design’ practical: when instrumentation, data, and workflows are standardized, robust sequence-screening and chain-of-custody checks become automatic rather than optional. Harmonized international standards will let every lab, anywhere, benefit from the same baseline of security and reproducibility.

D.J. Kleinbaum leads Emerald Cloud Lab, a remotely operated, highly automated research facility and software platform that virtualizes wet-lab science and drives reproducibility at scale. He co-founded ECL after starting Emerald Therapeutics, spinning out the cloud-lab platform to serve researchers across industry and academia. ECL now enables scientists to design, run, and analyze experiments end-to-end from anywhere—an approach increasingly relevant to standardized, auditable biosafety and biosecurity workflows.

Kleinbaum earned a Ph.D. in Chemistry at Stanford University (Kool Lab) and a B.S. in Biological Sciences from Carnegie Mellon University. His academic work focused on DNA-templated and bioorthogonal reactions for nucleic-acid detection in living cells, with publications in Journal of the American Chemical Society, Bioconjugate Chemistry, and Chemical Communications (e.g., “Sandwich probes” and “Double Displacement” strategies). He is also an inventor on multiple patents.